I believe tomorrow marks a minor leveling of the p
Post# of 72440
(Total Views: 653)
Posted On: 09/08/2021 9:18:57 PM
I believe tomorrow marks a minor leveling of the playing field in the trading of IPIX stock as IMO the Jewish holidays yesterday and today could have held up PRs. Whether it did or not is immaterial, just saying that it could have been a factor.
Tomorrow nobody has a clue as when an actual PR will be issued or what it will contain, but now all players have to realize it could come at any hour of the day on any day of the week starting Thursday, 9/9.
IMO there has not been many trial reporting results where expectations were so high based on the science, the SI, the historical data of in vivo results mirroring in vitro results, and the drug having been designed using many thousands of hours on a super computer to refine the formulation to maximize benefits, minimize side effects, provide for such a stalwart safety profile, and have been designed by a more qualified creator.
I am among those that put way more into IPIX than was reasonable for any sane person, but my confidence is such that I can see no possible way the trial can't be a major success because science does not falter but remains constant.
I hope there is an armada of news that will forthcoming in the next month and Brilacidin will become a daily headline featured story as the extent of its capabilities become publicized.
Looking like a GREAT time leading into the holiday season and a very, very positive 2022.
Have to admit, hard to believe the long wait is over and all the agonizing over the years has paid off in what I still believe will be the "Perfect Storm" of Brilacidin and IPIX.
Also nice to know that due to financial changes expected in the near future Kevetrin should get thru tox tests sometime in the near future (won't estimate the number of months) and I believe as 2022 progresses we see an ungodly amount of complementary trials for it with nearly all the current cancer drugs and treatments now in use.
Strictly my WAG.
Tomorrow nobody has a clue as when an actual PR will be issued or what it will contain, but now all players have to realize it could come at any hour of the day on any day of the week starting Thursday, 9/9.
IMO there has not been many trial reporting results where expectations were so high based on the science, the SI, the historical data of in vivo results mirroring in vitro results, and the drug having been designed using many thousands of hours on a super computer to refine the formulation to maximize benefits, minimize side effects, provide for such a stalwart safety profile, and have been designed by a more qualified creator.
I am among those that put way more into IPIX than was reasonable for any sane person, but my confidence is such that I can see no possible way the trial can't be a major success because science does not falter but remains constant.
I hope there is an armada of news that will forthcoming in the next month and Brilacidin will become a daily headline featured story as the extent of its capabilities become publicized.
Looking like a GREAT time leading into the holiday season and a very, very positive 2022.
Have to admit, hard to believe the long wait is over and all the agonizing over the years has paid off in what I still believe will be the "Perfect Storm" of Brilacidin and IPIX.
Also nice to know that due to financial changes expected in the near future Kevetrin should get thru tox tests sometime in the near future (won't estimate the number of months) and I believe as 2022 progresses we see an ungodly amount of complementary trials for it with nearly all the current cancer drugs and treatments now in use.
Strictly my WAG.
(10)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼